These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene. Uto H, Ido A, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H. Biochem Biophys Res Commun; 1999 Nov 19; 265(2):550-5. PubMed ID: 10558907 [Abstract] [Full Text] [Related]
9. A novel approach for inducing enhanced and selective transgene expression in hepatocellular-carcinoma cells. Cao G, Kuriyama S, Tsujinoue H, Chen Q, Mitoro A, Qi Z. Int J Cancer; 2000 Jul 15; 87(2):247-52. PubMed ID: 10861483 [Abstract] [Full Text] [Related]
10. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences. Arbuthnot P, Bralet MP, Thomassin H, Danan JL, Bréchot C, Ferry N. Hepatology; 1995 Dec 15; 22(6):1788-96. PubMed ID: 7489990 [Abstract] [Full Text] [Related]
13. Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell. Shi YJ, Gong JP, Liu CA, Li XH, Mei Y, Mi C, Huo YY. World J Gastroenterol; 2004 Jan 15; 10(2):186-9. PubMed ID: 14716819 [Abstract] [Full Text] [Related]
14. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter. Ishikawa H, Nakata K, Mawatari F, Ueki T, Tsuruta S, Ido A, Nakao K, Kato Y, Ishii N, Eguchi K. Biochem Biophys Res Commun; 2001 Oct 05; 287(4):1034-40. PubMed ID: 11573968 [Abstract] [Full Text] [Related]